EGM
PACB icon

Engineers Gate Manager’s Pacific Biosciences PACB Stock Holding History

Engineers Gate Manager’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Buy
52,289
+30,818
+144% +$55.1K ﹤0.01% 2063
2025
Q4 		$40.2K Buy
+21,471
New +$41.3K ﹤0.01% 1995
2025
Q3 		– Sell
-88,827
Closed -$110K – 2432
2025
Q2 		$110K Buy
+88,827
New +$103K ﹤0.01% 1982
2024
Q3 		– Sell
-102,260
Closed -$140K – 2322
2024
Q2 		$140K Sell
102,260
-195,611
-66% -$395K ﹤0.01% 1701
2024
Q1 		$1.12M Buy
297,871
+277,071
+1,332% +$1.62M 0.03% 762
2023
Q4 		$204K Buy
+20,800
New +$170K 0.01% 1634
2022
Q2 		– Sell
-402,217
Closed -$3.66M – 2161
2022
Q1 		$3.66M Buy
402,217
+389,169
+2,983% +$4.48M 0.14% 155
2021
Q4 		$267K Sell
13,048
-11,619
-47% -$280K 0.01% 1478
2021
Q3 		$630K Sell
24,667
-21,711
-47% -$643K 0.04% 744
2021
Q2 		$1.62M Buy
+46,378
New +$1.35M 0.1% 237
2021
Q1 		– Sell
-13,370
Closed -$347K – 2049
2020
Q4 		$347K Sell
13,370
-18,251
-58% -$310K 0.02% 1202
2020
Q3 		$312K Sell
31,621
-9,538
-23% -$54.9K 0.01% 1229
2020
Q2 		$142K Buy
41,159
+8,703
+27% +$29.6K 0.01% 1518
2020
Q1 		$99K Sell
32,456
-149,407
-82% -$612K 0.01% 1416
2019
Q4 		$935K Sell
181,863
-8,296
-4% -$42.2K 0.04% 678
2019
Q3 		$981K Buy
+190,159
New +$1.06M 0.05% 546
2018
Q4 		– Sell
-165,321
Closed -$894K – 1064
2018
Q3 		$894K Buy
+165,321
New +$709K 0.07% 372

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Engineers Gate Manager's PACB Position: Q1 2026 in Review

Engineers Gate Manager increased its Pacific Biosciences (PACB) stake by 144% in Q1 2026, buying an estimated $55.1K and bringing the position to 52,289 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.

Engineers Gate Manager first reported a position in PACB in Q3 2018 and has held it in 17 quarters since. The position peaked at $3.66M in Q1 2022. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Engineers Gate Manager held 52,289 shares of Pacific Biosciences worth $69K as of Q1 2026.
  • Engineers Gate Manager bought 30,818 Pacific Biosciences shares in Q1 2026, an estimated $55.1K.
  • Pacific Biosciences made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #2063 holding.
  • Engineers Gate Manager first reported a position in Pacific Biosciences in Q3 2018 and has held it in 17 quarters since.
  • Engineers Gate Manager's Pacific Biosciences position peaked at $3.66M in Q1 2022.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.